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Abstract
Since the discovery of the SUMO (small ubiquitin-like modifier) family of proteins just over a
decade ago, a plethora of substrates have been uncovered including many regulators of
transcription. Conjugation of SUMO to target proteins has generally been considered as a
repressive modification. However, there are now a growing number of examples where
sumoylation has been shown to activate transcription. Here we discuss whether there is something
intrinsically repressive about sumoylation, or if the outcome of this modification in the context of
transcription will prove to be largely substrate-dependent. We highlight some of the technical
challenges that will be faced by attempting to answer this question.
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How does SUMO regulate transcription?
There is now substantial evidence for the involvement of SUMO modification in the
regulation of gene expression [1, 2]. From first principles, a number of mechanisms by
which this regulation might occur are apparent and these are illustrated in Figure 1. Firstly, it
could be that sumoylation of a transcription factor could affect its binding to DNA
promoting either its association or dissociation from specific promoters (Figure 1A). This
hypothesis is tempting because SUMO carries a negative charge (pI = 5.2), and so it is easy
to imagine how this could interfere with DNA binding by a basic transcription factor.
However, a clear example of this type of regulation shows that SUMO modification can also
promote DNA binding. In the case with stress induced sumoylation of heat shock
transcription factor 1 (HSF1), conjugation of SUMO in fact stimulates the ability of HSF1 to
bind DNA and therefore presumably its capacity to regulate genes that respond to heat shock
[3]. Alternatively, sumoylation could promote or inhibit protein-protein interactions leading
to differential recruitment of activities that might activate or repress gene transcription
(Figure 1B). Such regulation of protein interactions could also impinge on transcription
indirectly, perhaps by antagonizing ubiquitin-mediated degradation or influencing the
subcellular localisation of partner proteins required either for activation or repression [4, 5].
Finally, it is possible that SUMO modification could affect enzymatic activities of proteins
that regulate gene expression (Figure 1C). For example the de novo DNA methyltransferase
Dnmt3a [6] is reported to be a substrate for SUMO modification as are a number of histone
deacetylases [7, 8] as well as a histone acetyltransferase Gcn5 [9] and a histone
methyltransferase Clr4 [10]. It remains to be determined to what extent SUMO modification
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sdirectly regulates the catalytic activities of these proteins and whether other enzymes that
modulate histone modifications and gene expression, such as JmjC domain containing
histone demethylases [11], can be subject to sumoylation. The regulatory mechanisms
discussed here are not mutually exclusive and the challenge is to work out how each
contributes to the regulation of various sumoylated proteins. None of these mechanisms
immediately suggest that SUMO should preferentially either promote or antagonize
transcription.
Technical difficulties in studying the role of SUMO
Before being able to investigate any of these putative mechanisms in detail, it is first
necessary to identify proteins that are targets for sumoylation. Determining bona fide
sumoylation targets in vivo and elucidating the physiological outcome of their modification
is not a straightforward task. SUMO proteases can be much more promiscuous in cellular
extracts made under native conditions than they are in vivo making biochemical analysis of
many native sumoylated proteins extremely difficult [12]. Furthermore analyses of the role
of SUMO in mammalian systems has depended heavily on the use of protein overexpression
and transiently transfected reporter genes, which may not give a true reflection of the
physiological roles of the proteins being studied in all cases. Even using RNAi to test the
effect of depleting the endogenous pool of SUMO represents an extremely crude
manipulation due to the number of different substrates of this modification and so there is a
great danger of observing indirect effects. The most surgical experiments where lysines
targeted for sumoylation are mutated carry several caveats: In mammalian systems these
almost invariably involve overexpression of the sumoylation substrate and there is always
the formal possibility that the observed effects are due to disruption of another post-
translational modification of lysine such as ubiquitination, acetylation and methylation.
However, mutations in glutamate within the conserved sumoylation motif (ΨKxE), which
are less likely to affect other modifications of the neighbouring lysine, could be more
informative. Also, in contrast to many kinases and phosphatases, specific small molecule
inhibitors of SUMO ligases and proteases that can be administered to cells and used to
dissect their function in vivo are not yet available.
SUMO modification in transcriptional repression
In spite of these difficulties, a growing number of substrates have been identified which are
now allowing attempts to dissect mechanisms of transcriptional regulation by SUMO in
detail. Many case studies have led to the suggestion that modification of transcription factors
has a general role in transcriptional repression [1, 2]. Also the fact that targeting the SUMO
E2 enzyme Ubc9 to a promoter was sufficient to repress transcription has led to this idea
gaining further acceptance [13]. Another recent paper focussing on histone sumoylation in
budding yeast revealed that mutation of sumoylation sites in histone H2B led to increased
basal expression of several non-induced genes [14]. Also increased global histone
acetylation was observed in a yeast strain with reduced histone sumoylation due to a
temperature sensitive mutation in Ubc9 [14]. Given the association between histone
acetylation and transcriptional activation, this evidence is consistent with a general role for
SUMO modification in transcriptional repression. Furthermore, in fission yeast, SUMO is
required for proper silencing of genes inserted into heterochromatic regions [10]. There is
also evidence that SUMO is associated with repression in mammalian systems too. A series
of elegant papers from the Sharrocks laboratory have uncovered a role for sumoylation of
Elk-1 in the repression of genes activated by the MAP kinase signalling cascade [15-18]. In
the basal state Elk-1 is SUMO modified leading to recruitment of HDAC2 and repression of
target genes [15, 16]. However, when the pathway is activated by ERK, Elk-1 is
phosphorylated concomitant with loss of SUMO and HDAC2 are lost leading to full
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sactivation of target genes [15]. Alternatively, if the pathway is activated by stress (p38) then
sumoylation of Elk-1 is maintained in spite of its phosphorylation leading to only partial
activation of target genes [18].
SUMO modification in transcriptional activation
Alongside this evidence for a role for SUMO in transcriptional repression, there are now a
growing number of cases where sumoylation has been shown to activate transcription. For
example, SUMO modification of p53 stimulates its ability to activate reporter genes possibly
by competing against Mdm2-mediated ubiquitination, which targets p53 for degradation [19,
20]. Also, sumoylation of Tcf-4 by PIASγ increases its transcriptional activation in response
to β-catenin although it is not currently known how this effect is brought about because
SUMO modification does not inhibit the ability of Tcf-4 to associate with either β-catenin or
DNA [21]. However, there are examples of SUMO modification contributing to gene
activation where a mechanistic explanation is clearly emerging. In the case of de novo DNA
cytosine methyltransferases Dnmt3a SUMO modification disrupts its interaction with
HDAC1 and HDAC2 and inhibits its ability to repress in reporter assays [6]. Another nice
illustration of a mechanism for SUMO mediated activation being unravelled is that
repression by the transcription factor Ikaros was shown to be perturbed by double
modification with SUMO at two lysines in the N-terminus of the protein [22]. In this case it
was shown that sumoylation interferes with the interaction of Ikaros with the Sin3 and
NuRD co-repressor complexes and so a mechanism for the derepression of transcription is
clearly suggested [22]. Recently we and others have provided evidence that the methyl-CpG
binding transcriptional repressor MBD1 is SUMO modified in a variety of cell lines [23,
24]. Uchimura et al found that modification of MBD1 by SUMO2/3 stimulates its
interaction with the co-repressor MCAF in vitro [24]. They also showed that if SUMO-1 or
SUMO-2 and 3 are depleted by RNAi, then MCAF is lost from MBD1-containing
heterochromatic foci [24]. Given that MCAF is required for efficient reporter gene silencing
by MBD1 [25], this evidence implies that sumoylation will have a positive role in MBD1-
mediated transcriptional repression. In contrast, we found that conjugation of SUMO1 to
MBD1 by PIAS1 and PIAS3 E3 SUMO ligases disrupts the interaction of MBD1 with the
histone H3 lysine 9 (H3-K9) methyltransferase SETDB1. This leads to loss of the silencing
chromatin modification (H3-K9 trimethylation) at the promoter of an endogenous MBD1
target gene, p53BP2, and derepression of transcription [23]. Interestingly, sumoylated
MBD1 binds to SETDB1 in vitro but not in vivo suggesting that interaction of MBD1-
SUMO1 with another partner protein may inhibit the assembly of the co-repressor complex
with SETDB1 [23]. Thus conjugation of SUMO1 and SUMO2/3 has opposing effect on
MBD1 function and may serve to recruit different partner proteins. In the case of MBD1, as
with many other proteins, the balance between SUMO ligase and SUMO isopeptidase
activities is probably crucial for the assembly of specific protein complexes. How SUMO
conjugation/deconjugation machinery is regulated in response to physiological stimuli will
be an intriguing question to answer.
Given that there are now a number of examples of sumoylation contributing to gene
activation and light is being thrown on the general mechanisms by which this can occur,
further examples of roles for SUMO in positive regulation of transcription are likely to
emerge. The most challenging task, however, remains identification of proteins recognizing
not only SUMO itself but interacting specifically with SUMO modified proteins.
Conclusions
Many cases are now documented where sumoylation either disrupts or stimulates protein-
protein interactions, so it seems likely that this will prove to be far and away the most
Lyst and Stancheva Page 3
Biochem Soc Trans. Author manuscript; available in PMC 2010 May 17.
 
E
u
r
o
p
e
 
P
M
C
 
F
u
n
d
e
r
s
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
s
 
E
u
r
o
p
e
 
P
M
C
 
F
u
n
d
e
r
s
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
scommon mechanism by which SUMO-dependent regulation of transcription is achieved.
Thus far, in many cases only relatively simple models have been produced. It will be of
great interest to determine whether there are cases where sumoylation simultaneously
inhibits the association of a substrate with one protein whilst promoting the formation of a
complex with another. For example does sumoylation of MBD1 simply achieve
derepression of a target gene by disrupting the interaction of MBD1 with SETDB1 leading
to passive loss of histone H3 lysine K9 methylation at promoter nucleosomes during DNA
replication? Or does MBD1 sumoylation also lead to recruitment of a demethylase activity
making gene induction an active process? Similar questions can be asked in other cases
where conjugation of SUMO has been shown to promote or inhibit a single protein-protein
interaction. Answers to such questions might give us better understanding of how promoters
can produce subtle and temporally regulated changes in transcription in response to different
stimuli – a central problem in molecular biology.
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sFigure 1. Plausible mechanisms for regulation of transcription by SUMO
(A) SUMO may affect DNA binding of transcription factors. (B) SUMO could facilitate or
inhibit protein-protein interactions between transcription factor and co-repressor or co-
activator proteins. (C) SUMO could promote or inhibit enzymatic activities associated with
co-repressor or co-activator complexes.
Lyst and Stancheva Page 6
Biochem Soc Trans. Author manuscript; available in PMC 2010 May 17.
 
E
u
r
o
p
e
 
P
M
C
 
F
u
n
d
e
r
s
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
s
 
E
u
r
o
p
e
 
P
M
C
 
F
u
n
d
e
r
s
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
s